169 related articles for article (PubMed ID: 36398446)
1. Effects of Eligibility Criteria on Patient Selection and Treatment Implications from 10 Multidomain Dementia Prevention Trials: A Population-Based Study.
Licher S; Wolters FJ; Pavlović J; Kavousi M; Leening MJG; Ikram MK; Ikram MA
Neuroepidemiology; 2023; 57(1):14-24. PubMed ID: 36398446
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial.
Coley N; Coniasse-Brioude D; Igier V; Fournier T; Poulain JP; Andrieu S;
Alzheimers Res Ther; 2021 Sep; 13(1):157. PubMed ID: 34560903
[TBL] [Abstract][Full Text] [Related]
4. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial.
Rosenberg A; Ngandu T; Rusanen M; Antikainen R; Bäckman L; Havulinna S; Hänninen T; Laatikainen T; Lehtisalo J; Levälahti E; Lindström J; Paajanen T; Peltonen M; Soininen H; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Solomon A; Kivipelto M
Alzheimers Dement; 2018 Mar; 14(3):263-270. PubMed ID: 29055814
[TBL] [Abstract][Full Text] [Related]
5. Multi-Domain Interventions for Dementia Prevention - A Systematic Review.
Castro CB; Costa LM; Dias CB; Chen J; Hillebrandt H; Gardener SL; Brown BM; Loo RL; Garg ML; Rainey-Smith SR; Martins RN; Sohrabi HR
J Nutr Health Aging; 2023; 27(12):1271-1280. PubMed ID: 38151879
[TBL] [Abstract][Full Text] [Related]
6. Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study-A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline.
Röhr S; Zülke A; Luppa M; Brettschneider C; Weißenborn M; Kühne F; Zöllinger I; Samos FZ; Bauer A; Döhring J; Krebs-Hein K; Oey A; Czock D; Frese T; Gensichen J; Haefeli WE; Hoffmann W; Kaduszkiewicz H; König HH; Thyrian JR; Wiese B; Riedel-Heller SG
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33430189
[TBL] [Abstract][Full Text] [Related]
7. Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials.
Coley N; Ngandu T; Lehtisalo J; Soininen H; Vellas B; Richard E; Kivipelto M; Andrieu S;
Alzheimers Dement; 2019 Jun; 15(6):729-741. PubMed ID: 31047857
[TBL] [Abstract][Full Text] [Related]
8. Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index.
van Middelaar T; Hoevenaar-Blom MP; van Gool WA; Moll van Charante EP; van Dalen JW; Deckers K; Köhler S; Richard E
Alzheimers Res Ther; 2018 Jun; 10(1):62. PubMed ID: 29960597
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease.
Kivipelto M; Mangialasche F; Ngandu T
Nat Rev Neurol; 2018 Nov; 14(11):653-666. PubMed ID: 30291317
[TBL] [Abstract][Full Text] [Related]
10. Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment.
Richard E; Jongstra S; Soininen H; Brayne C; Moll van Charante EP; Meiller Y; van der Groep B; Beishuizen CR; Mangialasche F; Barbera M; Ngandu T; Coley N; Guillemont J; Savy S; Dijkgraaf MG; Peters RJ; van Gool WA; Kivipelto M; Andrieu S
BMJ Open; 2016 Jun; 6(6):e010806. PubMed ID: 27288376
[TBL] [Abstract][Full Text] [Related]
11. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis.
Hughes D; Judge C; Murphy R; Loughlin E; Costello M; Whiteley W; Bosch J; O'Donnell MJ; Canavan M
JAMA; 2020 May; 323(19):1934-1944. PubMed ID: 32427305
[TBL] [Abstract][Full Text] [Related]
12. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
13. Determinants of Dropout and Nonadherence in a Dementia Prevention Randomized Controlled Trial: The Prevention of Dementia by Intensive Vascular Care Trial.
Beishuizen CRL; Coley N; Moll van Charante EP; van Gool WA; Richard E; Andrieu S
J Am Geriatr Soc; 2017 Jul; 65(7):1505-1513. PubMed ID: 28263374
[TBL] [Abstract][Full Text] [Related]
14. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Barnard S; Perel P; Free C
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
[TBL] [Abstract][Full Text] [Related]
15. Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6.
Solomon A; Stephen R; Altomare D; Carrera E; Frisoni GB; Kulmala J; Molinuevo JL; Nilsson P; Ngandu T; Ribaldi F; Vellas B; Scheltens P; Kivipelto M;
Alzheimers Res Ther; 2021 Oct; 13(1):171. PubMed ID: 34635167
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial.
Moll van Charante EP; Richard E; Eurelings LS; van Dalen JW; Ligthart SA; van Bussel EF; Hoevenaar-Blom MP; Vermeulen M; van Gool WA
Lancet; 2016 Aug; 388(10046):797-805. PubMed ID: 27474376
[TBL] [Abstract][Full Text] [Related]
17. Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial.
Barbera M; Mangialasche F; Jongstra S; Guillemont J; Ngandu T; Beishuizen C; Coley N; Brayne C; Andrieu S; Richard E; Soininen H; Kivipelto M;
J Alzheimers Dis; 2018; 62(2):649-663. PubMed ID: 29480185
[TBL] [Abstract][Full Text] [Related]
18. A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial.
Zülke AE; Pabst A; Luppa M; Roehr S; Seidling H; Oey A; Cardona MI; Blotenberg I; Bauer A; Weise S; Zöllinger I; Sanftenberg L; Brettschneider C; Döhring J; Lunden L; Czock D; Haefeli WE; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG
Alzheimers Dement; 2024 Jan; 20(1):615-628. PubMed ID: 37768074
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
